JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yolonda L. Colson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khullar, O.
Right arrow Articles by Colson, Y. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Khullar, O.
Right arrow Articles by Colson, Y. L.
Related Collections
Right arrow Lung - cancer
Right arrow Professional affairs

J Thorac Cardiovasc Surg 2009;138:275
© 2009 The American Association for Thoracic Surgery

Editorial

The underfunding of lung cancer research

Onkar Khullar, MD, Yolonda L. Colson, MD, PhD*

Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass

Received for publication May 5, 2009; accepted for publication May 5, 2009.

* Address for reprints: Yolonda L. Colson, MD, PhD, Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115. (Email: ylcolson@bics.bwh.harvard.edu).

The first 20% of the full text of this article appears below.

Despite major advances in the field of oncology in research, diagnostic methods, and treatment modalities, lung cancer remains the leading cause of cancer death in the United States among both men and women. With an estimated 215,020 new cases and 161,840 deaths in 2008, lung cancer is responsible for more than 25% of all cancer deaths.1,2Go Given these alarming statistics, one would assume that lung cancer research would be a priority for funding. Surprisingly, this could not be further from the truth. In terms of research funding, lung cancer is all but forgotten.

Various government agencies fund cancer research, including the National Institutes of Health (NIH) and National Cancer Institute (NCI), the Department of Defense (DOD), and the Centers for Disease Control and Prevention (CDC). Of the $5.570 billion in NIH funding for all cancer research . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.